Literature DB >> 30967505

Histone H3 tail binds a unique sensing pocket in EZH2 to activate the PRC2 methyltransferase.

Krupa S Jani1, Siddhant U Jain2,3, Eva J Ge1, Katharine L Diehl1, Stefan M Lundgren2,3, Manuel M Müller1, Peter W Lewis2,3, Tom W Muir4.   

Abstract

Enhancer of Zeste Homolog 2 (EZH2) is the catalytic subunit of Polycomb Repressor Complex 2 (PRC2), the enzyme that catalyzes monomethylation, dimethylation, and trimethylation of lysine 27 on histone H3 (H3K27). Trimethylation at H3K27 (H3K27me3) is associated with transcriptional silencing of developmentally important genes. Intriguingly, H3K27me3 is mutually exclusive with H3K36 trimethylation on the same histone tail. Disruptions in this cross-talk result in aberrant H3K27/H3K36 methylation patterns and altered transcriptional profiles that have been implicated in tumorigenesis and other disease states. Despite their importance, the molecular details of how PRC2 "senses" H3K36 methylation are unclear. We demonstrate that PRC2 is activated in cis by the unmodified side chain of H3K36, and that this activation results in a fivefold increase in the k cat of its enzymatic activity catalyzing H3K27 methylation compared with activity on a substrate methylated at H3K36. Using a photo-cross-linking MS strategy and histone methyltransferase activity assays on PRC2 mutants, we find that EZH2 contains a specific sensing pocket for the H3K36 methylation state that allows the complex to distinguish between modified and unmodified H3K36 residues, altering enzymatic activity accordingly to preferentially methylate the unmodified nucleosome substrate. We also present evidence that this process may be disrupted in some cases of Weaver syndrome.

Entities:  

Keywords:  PRC2 methyltransferase; chemical biology; designer chromatin

Mesh:

Substances:

Year:  2019        PMID: 30967505      PMCID: PMC6486736          DOI: 10.1073/pnas.1819029116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Crystal structure and functional analysis of the histone methyltransferase SET7/9.

Authors:  Jonathan R Wilson; Chun Jing; Philip A Walker; Stephen R Martin; Steven A Howell; G Michael Blackburn; Steven J Gamblin; Bing Xiao
Journal:  Cell       Date:  2002-10-04       Impact factor: 41.582

2.  Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Authors:  Ru Cao; Liangjun Wang; Hengbin Wang; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

3.  Baculovirus expression system for heterologous multiprotein complexes.

Authors:  Imre Berger; Daniel J Fitzgerald; Timothy J Richmond
Journal:  Nat Biotechnol       Date:  2004-11-28       Impact factor: 54.908

4.  The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.

Authors:  Robert J Klose; Kenichi Yamane; Yangjin Bae; Dianzheng Zhang; Hediye Erdjument-Bromage; Paul Tempst; Jiemin Wong; Yi Zhang
Journal:  Nature       Date:  2006-05-28       Impact factor: 49.962

5.  Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.

Authors:  Andrei Kuzmichev; Kenichi Nishioka; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

6.  Haploinsufficiency of NSD1 causes Sotos syndrome.

Authors:  Naohiro Kurotaki; Kiyoshi Imaizumi; Naoki Harada; Mitsuo Masuno; Tatsuro Kondoh; Toshiro Nagai; Hirofumi Ohashi; Kenji Naritomi; Masato Tsukahara; Yoshio Makita; Tateo Sugimoto; Tohru Sonoda; Tomoko Hasegawa; Yasuaki Chinen; Hiro-aki Tomita Ha; Akira Kinoshita; Tsuyoshi Mizuguchi; Koh-ichiro Yoshiura Ki; Tohru Ohta; Tatsuya Kishino; Yoshimitsu Fukushima; Norio Niikawa; Naomichi Matsumoto
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

7.  Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.

Authors:  Min Gyu Lee; Raffaella Villa; Patrick Trojer; Jessica Norman; Kai-Ping Yan; Danny Reinberg; Luciano Di Croce; Ramin Shiekhattar
Journal:  Science       Date:  2007-08-30       Impact factor: 47.728

8.  Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

Authors:  Antonis Kirmizis; Stephanie M Bartley; Andrei Kuzmichev; Raphael Margueron; Danny Reinberg; Roland Green; Peggy J Farnham
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

9.  Partial NSD1 deletions cause 5% of Sotos syndrome and are readily identifiable by multiplex ligation dependent probe amplification.

Authors:  J Douglas; K Tatton-Brown; K Coleman; S Guerrero; J Berg; T R P Cole; D Fitzpatrick; Y Gillerot; H E Hughes; D Pilz; F L Raymond; I K Temple; A Irrthum; J P Schouten; N Rahman
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

10.  Sotos syndrome.

Authors:  Katrina Tatton-Brown; Nazneen Rahman
Journal:  Eur J Hum Genet       Date:  2006-09-13       Impact factor: 4.246

View more
  27 in total

1.  Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.

Authors:  Siddhant U Jain; Sima Khazaei; Dylan M Marchione; Stefan M Lundgren; Xiaoshi Wang; Daniel N Weinberg; Shriya Deshmukh; Nikoleta Juretic; Chao Lu; C David Allis; Benjamin A Garcia; Nada Jabado; Peter W Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-16       Impact factor: 11.205

2.  Structural basis for PRC2 decoding of active histone methylation marks H3K36me2/3.

Authors:  Ksenia Finogenova; Jacques Bonnet; Simon Poepsel; Ingmar B Schäfer; Katja Finkl; Katharina Schmid; Claudia Litz; Mike Strauss; Christian Benda; Jürg Müller
Journal:  Elife       Date:  2020-11-19       Impact factor: 8.140

3.  PRC2 engages a bivalent H3K27M-H3K27me3 dinucleosome inhibitor.

Authors:  Katharine L Diehl; Eva J Ge; Daniel N Weinberg; Krupa S Jani; C David Allis; Tom W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

Review 4.  Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high-grade gliomas.

Authors:  L H Kasper; S J Baker
Journal:  Neuropathol Appl Neurobiol       Date:  2020-01-07       Impact factor: 8.090

Review 5.  Domain cross-talk in regulation of histone modifications: Molecular mechanisms and targeting opportunities.

Authors:  James E Longbotham; Meng Yao Zhang; Danica Galonić Fujimori
Journal:  Curr Opin Chem Biol       Date:  2020-08-03       Impact factor: 8.822

6.  Getting a handle on chemical probes of chomatin readers.

Authors:  Jarod M Waybright; Lindsey I James
Journal:  Future Med Chem       Date:  2020-01-10       Impact factor: 3.808

Review 7.  The interplay between DNA and histone methylation: molecular mechanisms and disease implications.

Authors:  Yinglu Li; Xiao Chen; Chao Lu
Journal:  EMBO Rep       Date:  2021-04-12       Impact factor: 8.807

Review 8.  The potential role of lncRNAs in osteoporosis.

Authors:  Yinxi He; Yanxia Chen
Journal:  J Bone Miner Metab       Date:  2021-02-10       Impact factor: 2.626

9.  Efficacy of PARP inhibition combined with EZH2 inhibition depends on BRCA mutation status and microenvironment in breast cancer.

Authors:  Mei-Kuang Chen
Journal:  FEBS J       Date:  2021-02-11       Impact factor: 5.542

Review 10.  Interplay between chromatin marks in development and disease.

Authors:  Sanne M Janssen; Matthew C Lorincz
Journal:  Nat Rev Genet       Date:  2021-10-04       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.